PathGroup is committed to providing state-of-the-art testing in more than 80,000 square feet of lab space, featuring innovative molecular, anatomic and validation labs to support Phase I−IV clinical trials. Our objective is to become an extension of your study team, collaborating on solutions to reach a common goal: optimized study outcomes.

Leadership and direction are provided by a dedicated BioPharma Services staff to oversee your project from start to finish. Our Quality Management team drives regulatory and risk management efforts for all stakeholders. PathGroup’s Data Management group utilizes the latest in proprietary and industry standard technology to provide custom databases and essential data reporting formats.

  • Diversified molecular pathology portfolio with actionable genomic variance data
  • NGS testing from single analyte, custom panel development including translocations
  • Proprietary extraction method for enhanced DNA/RNA isolation
  • Sophisticated bioinformatics suite with integrated solutions including data analysis and customized reporting capabilities

Areas of expertise within PathGroup’s full-service laboratory include:

  • Women’s Health
  • Dermatology
  • Hematology Oncology
  • Gastroenterology
  • Molecular Oncology
  • Urology
  • Infectious Diseases
  • Non-Gyn Cytopathology
  • Inherited Genetics
  • Soft Tissue and Bone Pathology
  • Pharmacogenomics
  • Breast Pathology
  • Validation and Development

PathGroup core technologies include:

  • Immunohistochemistry (IHC)
  • Flow Cytometry
  • Cytogenetics
  • Fluorescence in Situ Hybridization (FISH)
  • Chromogenic in Situ Hybridization (CISH)
  • Polymerase Chain Reaction (PCR)
  • DNA Sequencing: single analyte to comprehensive industry leading panels
  • Array-Based Comparative Genomic Hybridization (CGA)
  • High-Sensitivity and Specialty Assays

In keeping with PathGroup’s commitment to excellence in pathology, we are CAP accredited and CLIA certified.

Contact us to schedule time to discuss your project: